Kusnoor Anita V, Ferguson Angela D, Falik Ruth
Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
South Med J. 2011 Mar;104(3):200-4. doi: 10.1097/SMJ.0b013e31820bffd3.
Ischemic heart disease (IHD) is the leading cause of death among women in the Western world, and its prevalence is growing. The pathophysiology of heart disease in women differs from that in men. Women with chest pain and abnormal stress tests are less likely than men to have critical stenosis of coronary arteries, a phenomenon attributed to endothelial dysfunction. Hypertension, intimal injury, and cholesterol are among the various factors that contribute to endothelial dysfunction. The presenting symptoms of IHD also differ in women. Women are more likely to describe neck and throat pain and to characterize the pain as intense, sharp, or burning. A history of coronary or other vascular disease, diabetes, or chronic kidney disease places patients at high risk for IHD. Risk factor modification can be tailored based on each patient's risk. Hormone replacement therapy, antioxidants, folic acid, and aspirin in healthy women under 65 years of age have recently been shown to be ineffective in the prevention of IHD.
缺血性心脏病(IHD)是西方世界女性的主要死因,且其患病率正在上升。女性心脏病的病理生理学与男性不同。有胸痛和应激试验异常的女性比男性患冠状动脉严重狭窄的可能性更小,这一现象归因于内皮功能障碍。高血压、内膜损伤和胆固醇是导致内皮功能障碍的多种因素。IHD的临床表现症状在女性中也有所不同。女性更有可能描述颈部和喉咙疼痛,并将疼痛描述为剧烈、尖锐或灼痛。有冠状动脉或其他血管疾病、糖尿病或慢性肾病病史的患者患IHD的风险很高。可以根据每个患者的风险来调整危险因素的控制。最近研究表明,65岁以下健康女性使用激素替代疗法、抗氧化剂、叶酸和阿司匹林预防IHD无效。